Analytical Data
-
基因名
FAM160B1
- Application
-
别名
FAM160B1; KIAA1600Protein FAM160B1
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-SUMO
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q5W0V3
-
表达区间
1-738aa
-
分子量
99.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM160B1 is a protein-coding gene that has garnered attention in recent years for its potential roles in various biological processes and diseases. Initially identified as a gene with unknown function, FAM160B1 was later linked to the regulation of cellular mechanisms such as apoptosis, proliferation, and differentiation. Research indicates that FAM160B1 may be involved in the endosomal pathway and has been implicated in the modulation of immune responses. Studies suggest that its dysfunction could contribute to various pathologies, including neurological disorders and immune-related conditions. Given its significance, the production and study of recombinant FAM160B1 protein have become essential for elucidating its biological functions and interactions in cellular contexts. By generating this recombinant protein, researchers aim to facilitate the examination of FAM160B1's role in cellular signaling pathways and its potential as a therapeutic target. Additionally, understanding its structure may reveal insights into its mechanisms of action and facilitate the development of inhibitors or modulators that could have clinical relevance. As FAM160B1 is still under investigation, ongoing studies involving its recombinant form are vital for comprehensively mapping its functions and exploring its implications in health and disease.
